Afuresertib [1047644-62-1]
A225822
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameAfuresertib [1047644-62-1]
- Delivery Days Customer7
- CertificationResearch Use Only
- Scientific DescriptionInhibitor of Akt.; GSK-2110183C, GSK-2110183
- UNSPSC12352200
References
- Kinoshita S., Ri M., et al. Potent antitumor effect of combination therapy with sub-optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma. Oncol Lett. 15(6):9450-56 (2018). PMID: 29927335. Yamaji M., Ota A., et al. Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells. Cancer Med. 6(11):2646-59 (2017). PMID: 28960945.